

New Jabs for the Job
As the second wave of Covid-19 batters the country, the Indian government has approved the use of vaccines authorised in the US, UK, Europe and Japan to combat the dreaded disease. ET's Teena Thacker and Nidhi Sharma tell us about the challenges ahead and how soon will every citizen in India be vaccinatedSee…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from The Morning Brief
See all episodes →Similar episodes from other shows
More like The Morning Brief →
The Vaccine Scaling Problem

Cresting: India’s second covid-19 wave

Indian pharma: lofty aims in the midst of chaos

EU vaccine export tensions, a serious look at stock prices, India’s farmers
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.


